Sarcoma / 2017 / Article / Fig 3

Research Article

High-Dose Ifosfamide Chemotherapy in a Series of Patients Affected by Myxoid Liposarcoma

Figure 3

Overall progression-free survival (PFS) of patients treated with high-dose prolonged-infusion ifosfamide chemotherapy (11 patients). Median PFS was 1.9 months.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.